The aim of this study was to investigate the histopathological findings in kidney biopsies in children with atypical hemolytic uremic syndrome (aHUS) and to determine whether specific pathological findings in aHUS have a prognostic value.
Methods
Renal biopsy specimens of 29 patients who were recorded in the national Turkish aHUS registry database were available for review. Histopathological findings were compared with the clinical and laboratory features at the presentation and the final outcome.
Results
The mean age at presentation and follow-up period was 4.9 ± 3.9 and 3.9 ± 3.0 years, respectively. The median time interval from the first symptom to biopsy was 10 days. Vascular thrombosis and interstitial fibrosis were significantly related to chronic kidney disease (CKD) requiring dialysis or kidney transplantation during follow-up (5.6-fold, for both). Glomerular necrosis, cortical necrosis, and glomerular sclerosis were markedly associated with CKD without dialysis (6.2-fold, 13.3-fold, and 8.8-fold, respectively). However, presence of endothelial swelling, subendothelial widening, and fragmented erythrocytes was found to be correlated with a favorable final outcome.
Conclusions
Presence of vascular thrombosis, cortical necrosis, and glomerular sclerosis in histopathological evaluation correlated with developing CKD. Chronic changes in the interstitial compartment were also related to poor prognosis, a finding that has been shown for the first time in pediatric aHUS cases.
RainaRKrishnappaVBlahaTet al.
Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment. Ther Apher Dial.2019;
23: 4–21.
2.
JokirantaTS.
HUS and atypical HUS. Blood. 2017;
129: 2847–2856.
3.
WatersAMLichtC.
aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol.2011;
26: 41–57.
4.
Fremeaux-BacchiVFakhouriFGarnierAet al.
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013;
8: 554–562.
GargAXSuriRSBarrowmanNet al.
Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta regression. JAMA.2003;
290: 1360–1370.
7.
HoomanNOtukeshHDelshadSFarhoodP.
Surgical complications of hemolytic uremic syndrome: single center experiences. J Indian Assoc Pediatr Surg.2007;
12: 129–132.
8.
RodeghieroF.
Haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in southern Iran. Intern Emerg Med. 2006;
1: 248–249.
9.
FidanKGöknarNGülhanBet al.
Extra-renal manifestations of atypical hemolytic uremic syndrome in children. Pediatr Nephrol.2018;
33: 1395–1403.
10.
YuXJYuFSongDet al.
Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China. Scientific World J. Published online August 11, 2014. doi: 10.1155/2014/680502
11.
MehrazmaMHoomanNOtukeshH.
Prognostic value of renal pathological findings in children with atypical hemolytic uremic syndrome. Iran J Kidney Dis. 2011;
5: 380–385.
12.
Lazsik ZG, Kambham N, Silva FG. Thrombotic microangiopathies. In: Jenette JC, Olson JL, Silva FG, D’Agati VD, eds. Hepstintall’s Pathology of the Kidney. 7th ed. Philadelphia: Wolters Kluwer; 2015:739–814.
13.
LuscoMAFogoABNajafianBAlpersCE.
AJKD atlas of renal pathology: thrombotic microangiopathy. Am J Kidney Dis. 2016;
68: e33–e34.
Esparza-GordilloJGoicoechea de JorgeEBuilAet al.
Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet. 2005;
14: 703–712.
16.
CaprioliJCastellettiFBucchioniSet al.
Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet. 2003;
12: 3385–3395.
InwardCDHowieAJFitzpatrickMMRafaatFMilfordDVTaylorCM.
Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. British Association for Paediatric Nephrology. Pediatr Nephrol. 1997;
11: 556–559.
21.
RenaudCNiaudetPGagnadouxMFBroyerMHabibR.
Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age. Pediatr Nephrol. 1995;
9: 24–29.
22.
YükselSEvrengülHÖzçakarZBet al.
First-line, early and long-term eculizumab therapy in atypical hemolytic uremic syndrome: a case series in pediatric patients. Paediatr Drugs.2016;
18: 413–420.
23.
CalettiMGGalloGGianantonioCA.
Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome. Pediatr Nephrol.1996;
10: 687–692.
24.
MoghalNEFerreiraMAHowieAJMilfordDVRaafatETaylorCM.
The late histologic findings in diarrhea-associated hemolytic uremic syndrome. J Pediatr.1998;
133: 220–223.
25.
KarpmanDHåkanssonAPerezMTet al.
Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun.1998;
66: 636–644.
26.
SugiyamaHKashiharaNMakinoHYamasakiYOtaA.
Apoptosis in glomerular sclerosis. Kidney Int.1996;
49: 103–111.
BeckBBvan SpronsenFDiepstraABergerRMKömhoffM.
Renal thrombotic microangiopathy in patients with cblC defect: review of an underrecognized entity. Pediatr Nephrol. 2017;
32: 733–741.
29.
ChenMZhuangJYangJWangDYangQ.
Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia: a case report and literature review. Medicine (Baltimore). 2017;
96(43): e8284.
30.
HabibRGagnadouxMFBroyerM.
Hemolytic-uremic syndrome in children and arterial hypertension. Arch Mal Coeur Vaiss. 1981;
74: 37–43.
31.
Jenette JC, Olson JL, Silva FG, D’Agati VD. Primer on the pathologic classification and diagnosis of kidney disease. In: Jenette JC, Olson JL, Silva FG, D’Agati VD (eds). Hepstintall’s Pathology of the Kidney. 7th ed. Philadelphia: Wolters Kluwer; 2015:91–119.
32.
ZeisbergMNeilsonEG.
Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol. 2010;
21: 1819–1834.
33.
YuFWuLHTanYLiLHWangCLWangWK.
Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int. 2010;
77: 820–829.
34.
LimBJYangJWZouJet al.
Tubulointerstitial fibrosis can sensitize the kidney to subsequent glomerular injury. Kidney Int.2017;
92: 1395–1403.
35.
Olson JL. Renal disease caused by hypertension. In: Jenette JC, Olson JL, Silva FG, D’Agati VD, eds. Hepstintall’s Pathology of the Kidney. 7th ed. Philadelphia: Wolters Kluwer; 2015:849–896.
